Julie So-Young Kim sold $1.5M of TAK
President and CEO at TAKEDA PHARMACEUTICAL CO LTD. 89,090 shares at an average of $17.10, traded Aug 10, 2026, filed Aug 12, 2026.
Score components
- +25RoleCEO
- +25Trade size$1.5M at market
- +5Share of holdings soldSold 19% of holdings
- +15Cluster13 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-037484, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | SOpen-market sale American Depositary Shares | -89,090 | $17.10 | $1.5M | 391,489 | Aug 12, 2026 |
Related signals
Other insiders at TAKEDA PHARMACEUTICAL CO LTD and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | Lauren Rusckowski Duprey Chief Transformation Officer | $640k 34,535 shares | -15% | |
| 43Moderate | TAKEDA PHARMACEUTICAL CO LTD | Andrew Stewart Plump President, R&D | $2.1M 116,191 shares | -44% | |
| 30Weak | TAKEDA PHARMACEUTICAL CO LTD | Andrew Stewart Plump President, R&D | $363k 19,651 shares | -7% | |
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | Nicola Deidre Petal Greenway Chief Human Resources Officer | $235k 12,980 shares | -24% | |
| 63Notable | TAKEDA PHARMACEUTICAL CO LTD | Teresa Marie Bitetti President, OBU | $855k 50,012 shares | -17% | |
| 57Moderate | TAKEDA PHARMACEUTICAL CO LTD | Lauren Rusckowski Duprey Chief Transformation Officer | $814k 47,586 shares | -17% | |
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | Awny Samaan Botros Farajallah Chief Medical Officer | $240k 14,006 shares | -11% | |
| 53Moderate | TAKEDA PHARMACEUTICAL CO LTD | Natalie Anne Marie Furney Global General Counsel | $528k 30,868 shares | -13% | |
| 59Moderate | TAKEDA PHARMACEUTICAL CO LTD | Nicola Deidre Petal Greenway Chief Human Resources Officer | $606k 34,603 shares | -37% | |
| 45Moderate | TAKEDA PHARMACEUTICAL CO LTD | Nicola Deidre Petal Greenway Chief Human Resources Officer | $116k 6,774 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.